Spruce Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 02/18/2026 | 121.36 K | $10.57 M | 810.26% | 21.55% |
| 02/17/2026 | 70.00 K | $6.10 M | 100.00% | 12.43% | |
| CITADEL ADVISORS LLC | 02/17/2026 | 70.00 K | $6.10 M | 100.00% | 12.43% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 58.95 K | $5.14 M | 100.00% | 10.47% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 58.00 K | $5.05 M | 100.00% | 10.30% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 51.67 K | $4.50 M | 100.00% | 9.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 47.93 K | $4.18 M | 100.00% | 8.51% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 40.00 K | $3.48 M | 100.00% | 7.10% |
| CARLYLE GROUP INC. | 02/13/2026 | 38.62 K | $3.30 M | -98.67% | 6.86% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 25.27 K | $2.20 M | 100.00% | 4.49% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 24.77 K | $2.16 M | 100.00% | 4.40% |
| QUINN OPPORTUNITY PARTNERS LLC | 02/13/2026 | 22.81 K | $1.99 M | 100.00% | 4.05% |
| CALIGAN PARTNERS LP | 02/17/2026 | 20.51 K | $1.79 M | 100.00% | 3.64% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 19.74 K | $1.72 M | 100.00% | 3.51% |
| VANGUARD GROUP INC | 01/29/2026 | 17.87 K | $1.56 M | 100.00% | 3.17% |
| BLACKROCK, INC. | 02/12/2026 | 16.94 K | $1.48 M | 100.00% | 3.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 12.73 K | $1.11 M | 100.00% | 2.26% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 12.14 K | $1.06 M | 100.00% | 2.16% |
| STATE STREET CORP | 02/13/2026 | 6.40 K | $557.50 K | 100.00% | 1.14% |
| UBS GROUP AG | 01/29/2026 | 4.90 K | $427.01 K | 3,613.64% | 0.87% |
| RESOLUTE CAPITAL ASSET PARTNERS LLC | 02/17/2026 | 4.00 K | $348.44 K | 100.00% | 0.71% |
| SKYVIEW INVESTMENT ADVISORS, LLC | 02/18/2026 | 3.00 K | $261.00 K | 100.00% | 0.53% |
| NORTHERN TRUST CORP | 02/17/2026 | 2.42 K | $210.98 K | 100.00% | 0.43% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 2.00 K | $174.22 K | 100.00% | 0.36% |
| LION POINT CAPITAL, LP | 02/17/2026 | 1.00 K | $87.11 K | 0.00% | 0.18% |
| MORGAN STANLEY | 02/13/2026 | 388 | $33.80 K | 295.92% | 0.07% |
| SOUND INCOME STRATEGIES, LLC | 01/21/2026 | 200 | $14.71 K | 100.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 93 | $8.10 K | 3,000.00% | 0.02% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 84 | $7.32 K | 100.00% | 0.01% |
| ROYAL BANK OF CANADA | 02/17/2026 | 40 | $3.00 K | 100.00% | 0.01% |
| CALDWELL SUTTER CAPITAL, INC. | 01/30/2026 | 13 | $1.13 K | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1 | $87 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CABLE CAR CAPITAL LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Spruce Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Spruce Biosciences Inc. The most heavily invested institutionals were:
Ikarian Capital, LLC: 121,356
CITADEL ADVISORS LLC: 69,999
WELLINGTON MANAGEMENT GROUP LLP: 58,949
ADAR1 Capital Management, LLC: 58,000
Alyeska Investment Group, L.P.: 51,671
BOOTHBAY FUND MANAGEMENT, LLC: 47,933
133.88% of Spruce Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 5.56 M shares in the last 24 months. This purchase volume represents approximately $345.38 M in transactions.